VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2015 | The impact of the clinical trial of venetoclax (ABT-199) and obinutuzumab in CLL

Thomas Kipps, MD from the University of California, San Diego, CA, discussed the impact of the clinical trial of venetoclax (ABT-199) with obinutuzumab in the treatment landscape chronic lymphocytic leukemia (CLL).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter